Coherent Corp Reports Q3 Fiscal 2026 Results Market Awaits Details on Revenue and Earnings HP Inc Surpasses Wall Street Expectations with Latest Earnings and Optimistic Profit Outlook JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India MD Discusses Business Outlook Tourism Flow Reversal Turkish Tourists Surge to Greece as Cost Pressures Deter Greek Travelers HighYield Savings Rates on May 23 2026 Top Accounts Offer Up to 41 APY Top Tennis Stars Limit French Open Media Duties Amid Prize Money Dispute Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress Sachem Capital Corp SCCF Q4 2025 Earnings Massive EPS Beat on Minimal Expectations Core Natural Resources CNR Q1 2026 Earnings EPS Beats Estimates by 136 Amid Quiet Market Response OCS Q1 2026 Earnings WiderthanExpected Loss Weighs on Stock Incyte Corp INCY Q1 2026 Earnings Strong EPS Beat Overshadowed by Modest Stock Dip Deckers Outdoor DECK Gains 377 as Momentum Builds Toward Key Resistance Rezolute Inc RZLT Slides Amid Sector Pressure Key Levels to Watch Evertec Inc EVTC Edges Higher as Shares Test Resistance Near 26 Fortuna Mining Corp FSM Surges 444 Analysis of Key Levels and Outlook Blackrock MuniHoldings Fund MHD Gains 176 as Muni Bond Market Stabilizes DeEscalation Headlines Pressure Gold Prices as Memorial Day Weekend Approaches Oxford Lane Capital Corp Preferred Stock Shares 600 Series 2029 OXLCO Q4 2025 Earnings EPS Misses Estimates Despite Solid Operating Results Exelon EXC Holds Steady Near 46 as Utility Sector Provides Stability Winmark Corporation WINA Q1 2026 Earnings EPS Misses Estimates Amid Margin Headwinds DocGo Inc DCGO Q1 2026 Earnings EPS Misses as Revenue Data Remains Limited NIC Q1 2026 Earnings Significant EPS Miss Triggers Negative Market Reaction Sysco Corporation SYY Q1 2026 Earnings Slight EPS Miss Amid Steady Operational Performance QBTS Q1 2026 Earnings EPS Beats Estimates by 872 Shares Surge Revelation Biosciences Inc REVB Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Continues Development Xeris Biopharma Holdings Inc XERS Q1 2026 Earnings EPS Surprise Turns Positive as Stock Dips